Literature DB >> 5580101

Effect of L-dopa on brain monoamines and their metabolites in Parkinson's disease.

U K Rinne, V Sonninen, M Hyyppä.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5580101     DOI: 10.1016/0024-3205(71)90040-3

Source DB:  PubMed          Journal:  Life Sci I        ISSN: 0300-9653


× No keyword cloud information.
  12 in total

1.  Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases.

Authors:  V P Barkhatova; E I Kandel'; E G Demina
Journal:  Neurosci Behav Physiol       Date:  1985 Mar-Apr

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 3.  Antiparkinsonian drugs: pharmacological and therapeutic aspects.

Authors:  D B Calne; J L Reid
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  [Dopa resorption and dopamin estimation in blood of patients with Parkinson's disease (author's transl)].

Authors:  E Metzel; W U Weitbrecht
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974

5.  Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Sirtola
Journal:  Z Neurol       Date:  1972

6.  Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.

Authors:  W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

7.  Brain monoamines in human hepatic encephalopathy.

Authors:  K Jellinger; P Riederer; G Kleinberger; S Wuketich; P Kothbauer
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

8.  Dopamine receptors in the Parkinsonian brain.

Authors:  U K Rinne; P Lönnberg; V Koskinen
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

9.  Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.

Authors:  E Melamed; F Hefti; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  Brain amine concentrations after monoamine oxidase inhibitor administration.

Authors:  A B Jones; C M Pare; W J Nicholson; K Price; R S Stacey
Journal:  Br Med J       Date:  1972-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.